Bond.az White LogoBond.az Black Logo

Jyske Bank Buys Back 46,095 Shares

Jyske Bank repurchased 46,095 shares in week 20 at an average price of DKK 894.24. The buyback program aims for up to DKK 3 billion.

Sebastian Young
BySebastian Young- Senior Editor
|
0

Denmark's Jyske Bank purchased 46,095 shares during week 20 of 2026 at an average price of DKK 894.24.

The transactions occurred between May 11 and May 13. On May 11, the bank bought 16,067 shares at DKK 894.43; on May 12, 13,228 shares at DKK 891.10; and on May 13, 16,800 shares at DKK 896.14.

Total shares repurchased under the program reached 992,622, with a total value of DKK 897,569,609.

After settlement, Jyske Bank holds 4,302,150 treasury shares, representing 6.99% of share capital.

The buyback program started on February 5, 2026, and will run until January 29, 2027, with a maximum value of DKK 3 billion.

More News
Today / 07:43
|
570

Ocado Admits 62,729 Shares to London Stock Exchange

Ocado Group plc admits 62,729 ordinary shares to trading on the London Stock Exchange under the Restricted Share Plan.

0
Today / 07:04
|
876

Avacta reports 2025 results, raises £32.5m for oncology trials

Avacta Group reports 2025 preliminary results, raises £32.5 million for oncology trials. Updates on AVA6103 and AVA6000 programs.

0
Today / 07:02
|
489

Greatland Issues Shares for Employee Incentive Plan

Greatland Resources issues 1.76 million shares for employee incentive plan at A$14.11 each. Shares to be admitted to AIM trading.

0
Today / 06:46
|
625

Kidney Transplant Rejection Test Study Published

Verici Dx's study on kidney transplant rejection test published in Kidney360. PTRA test predicts early acute rejection better than traditional tools.

0
Today / 06:45
|
717

Power Metallic forms Saudi joint venture with Amaar Mining

Power Metallic and Amaar Mining form 50/50 joint venture in Saudi Arabia. Initial funding of $10 million.

0
Today / 06:43
|
917

Bayer's asundexian gets FDA priority review

FDA grants Priority Review to Bayer's asundexian for secondary stroke prevention. Phase III trial results show promise.

0
Today / 06:33
|
784

Orosur Mining Issues 2.85M Shares After RSU Exercise

Orosur Mining issues 2.85M shares after directors and consultants exercise RSUs. Shares to trade on AIM from May 22, 2026.

0
Today / 06:31
|
966

Golden Prospect Moves Portfolio Management to Manulife

Golden Prospect Precious Metals delegates portfolio management to Manulife. New managers Diana Racanelli and Craig Bethune appointed.

0
Today / 06:22
|
948

SSP Group Appoints Candace McGraw to Board

SSP Group appoints Candace McGraw as independent non-executive director. Effective June 1, she brings aviation expertise.

0
Today / 06:01
|
902

CBL-514: New Obesity Data Revealed

Caliway Biopharmaceuticals reveals new data on CBL-514 for obesity. Combination therapy boosts weight loss by 91.5%.

0
Today / 05:21
|
881

Genentech to Present Breast Cancer Data at ASCO Meeting

Genentech will present breast cancer data on giredestrant and other drugs at the 2026 ASCO meeting.

0
Today / 03:43
|
453

Onto Innovation prices $1.3B convertible notes

Onto Innovation prices $1.3 billion convertible senior notes due 2031 at a 50% conversion premium. Interest-free notes with strong liquidity.

0
...